UNISYS CORPORATION I
UNISYS CORPORATION INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Unisys Investors of a Class Action Lawsuit and Upcoming Deadline
02 déc. 2022 21h10 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Unisys Corporation (“Unisys” or the “Company”) (NYSE:...
Provident Bancorp In
Provident Bancorp Investor Alert: Kaplan Fox Investigates Provident Bancorp
25 nov. 2022 11h56 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”)...
Professional Diversity Network logo
Professional Diversity Network, Inc. Announces Third Quarter Results
13 nov. 2020 08h15 HE | Professional Diversity Network, Inc.
CHICAGO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (NASDAQ:IPDN), (“IPDN” or the “Company”), a global developer and operator of online and in-person networks that...
5bbc0be0f4fcb70004cdba11_1.jpg
Meso Numismatics Files 10-Q - Hosts Interview Featuring Green Pay Executive Team
28 août 2019 13h51 HE | Meso Numismatics, Inc.
LAS VEGAS, NV, Aug. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (OTC: MSSV), a technology and numismatic company specializing in the...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
09 août 2019 08h00 HE | VBI Vaccines, Inc.
Positive top-line data from PROTECT Phase 3 for Sci-B-Vac®, trivalent hepatitis B vaccine, announced June 2019 – top-line data from second Phase 3 study, CONSTANT, expected around year-end 2019ASCO...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update
09 nov. 2018 07h00 HE | VBI Vaccines, Inc.
­­ -- Completion of vaccination and enrollment in Sci-B-Vac® PROTECT and CONSTANT Phase 3 studies, respectively --  -- Encouraging early immunologic data observed in Phase 1/2a study of...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update
26 juil. 2018 07h00 HE | VBI Vaccines, Inc.
-- Pivotal Phase 3 program for Sci-B-Vac® Hepatitis B vaccine continues to advance towards topline data expected mid-year 2019 -- -- Positive safety and immunogenicity data from Phase 1 study of...
AIMLogo.jpg
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
10 nov. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...
Recovery Energy Logo
Recovery Energy, Inc. Announces the Filing of Its First Quarter Report on Form 10-Q
14 mai 2013 16h37 HE | Recovery Energy
DENVER, May 14, 2013 (GLOBE NEWSWIRE) -- Recovery Energy, Inc. (Nasdaq:RECV), an independent oil and gas exploration and production company with operations and assets in the Denver-Julesburg Basin,...
Aspire International Announces Intent to File All Quarterly Reports and Annual Report for 2011
18 avr. 2012 11h27 HE | Aspire International
TORONTO, April 18, 2012 (GLOBE NEWSWIRE) -- Aspire International Inc. (OTC:APIT) announced today that it expects to file all completed SEC Form 10-Q Quarterly Reports as well as its SEC From 10-K...